NICE Recommends Eisai Aricept For Patients With Mild To Moderate AD
This article was originally published in PharmAsia News
Executive Summary
The UK's National Institute for Health and Clinical Excellence has drafted guidance on the treatment of Alzheimer's disease, lifting previous restrictions on using drugs to treat patients with mild forms of the disease